We serve Chemical Name:4-Chloro-5-methoxypyrimidin-2-amine CAS:4763-36-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:4-Chloro-5-methoxypyrimidin-2-amine
CAS.NO:4763-36-4
Synonyms:4-chloro-5-methoxypyrimidin-2-amine
Molecular Formula:C5H6ClN3O
Molecular Weight:159.57400
HS Code:2933599090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:345.3ºC at 760 mmHg
Density:1.398g/cm3
Index of Refraction:1.585
PSA:61.03000
Exact Mass:159.02000
LogP:1.30200
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 4-chloro-5-methoxypyrimidin-2-amine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-chloro-5-methoxypyrimidin-2-amine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-chloro-5-methoxypyrimidin-2-amine Use and application,4-chloro-5-methoxypyrimidin-2-amine technical grade,usp/ep/jp grade.
Related News: The factory is part of a partnership with Nichepharm Lifesciences of India. Recipharm has an 8% stake in that company after an investment two years ago. (2,3,4,5,6-pentafluorophenyl) 6-(oxan-4-yloxy)pyridine-3-carboxylate manufacturers The factory is part of a partnership with Nichepharm Lifesciences of India. Recipharm has an 8% stake in that company after an investment two years ago. Methyl (3,5-dimethoxyphenyl)acetate suppliers Charles River Laboratories and AstraZeneca have maintained a strategic partnership since 2012, providing AstraZeneca with outsourced regulated safety and development support on a range of treatments and vaccines, including testing and facilitating the deployment of the vaccines Vaxzevria for COVID-19 and Fluenz for seasonal infleunza. 4-[3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]propyl]morpholine vendor & factory Founded in 1949 by Giovanni Stevanato, the packaging multinational is the world’s largest maker of cartridges for insulin pens and provides vials and syringes for 90% of the world’s Covid-19 vaccines.,The plant will complement Recipharm’s existing sites in France, Germany and Italy and will be focused on securing approvals from regulators in Europe and the U.S.
